Ignition of Small Molecule Inhibitors in Friedreich's Ataxia with Explainable Artificial Intelligence

Iron (Fe) chelating medicines and Histone deacetylase (HDAC) inhibitors are two therapy options for hereditary Friedreich's Ataxia that have been shown to improve clinical results (FA). Fe chelation molecules can minimize the quantity of stored Fe, and HDAC inhibitors can boost the expression o...

Full description

Bibliographic Details
Main Authors: Kevser Kübra Kirboğa, Ecir Uğur Küçüksille, Utku Kose
Format: Article
Language:English
Published: EduSoft publishing 2023-10-01
Series:Brain: Broad Research in Artificial Intelligence and Neuroscience
Subjects:
Online Access:https://www.edusoft.ro/brain/index.php/brain/article/view/1427
_version_ 1797335679160549376
author Kevser Kübra Kirboğa
Ecir Uğur Küçüksille
Utku Kose
author_facet Kevser Kübra Kirboğa
Ecir Uğur Küçüksille
Utku Kose
author_sort Kevser Kübra Kirboğa
collection DOAJ
description Iron (Fe) chelating medicines and Histone deacetylase (HDAC) inhibitors are two therapy options for hereditary Friedreich's Ataxia that have been shown to improve clinical results (FA). Fe chelation molecules can minimize the quantity of stored Fe, and HDAC inhibitors can boost the expression of the Frataxin (FXN) gene in enhancing FA. A complete quantitative structure-activity relationship (QSAR) search of inhibitors from the ChEMBL database is reported in this paper, which includes 437 compounds for Fe chelation and 1,354 compounds for HDAC inhibitors. For further investigation, the IC50 was chosen as the unit of bioactivity, and following data refinement, a final dataset of 436 and 1,163 compounds for Fe chelation and HDAC inhibition, respectively, was produced. The Random Forest (RF) technique was used to generate models (train R2 score, 0.701 and 0.892; test R2 score 0.572 and 0.460, for Fe and HDAC, respectively). The models created using the PubChem fingerprint were the strongest of the 12 fingerprint kinds; hence that feature was chosen for interpretation. The results showed the importance of properties related to nitrogen-containing functional groups (SHAP value of PubchemFP656 is -0.29) and aromatic rings (SHAP value of PubchemFP12 is -0.16). As a result, we explained the effect of the molecular fingerprints on the models and the impact on possible drugs that can be developed for FA with artificial intelligence (XAI), which can be explained through SHAP (Shapley Additive Explanations) values. Model scripts and fingerprinting methods are also available at https://github.com/tissueandcells/XAI.
first_indexed 2024-03-08T08:41:50Z
format Article
id doaj.art-e58b864259f54e91905fe29fbe7a9b76
institution Directory Open Access Journal
issn 2067-3957
language English
last_indexed 2024-03-08T08:41:50Z
publishDate 2023-10-01
publisher EduSoft publishing
record_format Article
series Brain: Broad Research in Artificial Intelligence and Neuroscience
spelling doaj.art-e58b864259f54e91905fe29fbe7a9b762024-02-01T18:00:44ZengEduSoft publishingBrain: Broad Research in Artificial Intelligence and Neuroscience2067-39572023-10-011432873131230Ignition of Small Molecule Inhibitors in Friedreich's Ataxia with Explainable Artificial IntelligenceKevser Kübra Kirboğa0Ecir Uğur Küçüksille1Utku Kose2PhD student at the Department of Computational Science and Engineering at Istanbul Technical University, BilecikSeyhEdebali University, Department of Bioengineering, Bilecik, Turkey, ORCID ID:0000-0002-2917-8860Suleyman Demirel University, EngineeringFaculty, ComputerEngineeringDepartment, 32260,Isparta, Turkey, ORCID ID:0000-0002-3293-9878Suleyman Demirel University, Turkey, University of North Dakota, USA, ORCID ID: https://orcid.org/0000-0002-9652-6415 , utkukose@gmail.com, utkukose@sdu.edu.tr, utku.kose@und.eduIron (Fe) chelating medicines and Histone deacetylase (HDAC) inhibitors are two therapy options for hereditary Friedreich's Ataxia that have been shown to improve clinical results (FA). Fe chelation molecules can minimize the quantity of stored Fe, and HDAC inhibitors can boost the expression of the Frataxin (FXN) gene in enhancing FA. A complete quantitative structure-activity relationship (QSAR) search of inhibitors from the ChEMBL database is reported in this paper, which includes 437 compounds for Fe chelation and 1,354 compounds for HDAC inhibitors. For further investigation, the IC50 was chosen as the unit of bioactivity, and following data refinement, a final dataset of 436 and 1,163 compounds for Fe chelation and HDAC inhibition, respectively, was produced. The Random Forest (RF) technique was used to generate models (train R2 score, 0.701 and 0.892; test R2 score 0.572 and 0.460, for Fe and HDAC, respectively). The models created using the PubChem fingerprint were the strongest of the 12 fingerprint kinds; hence that feature was chosen for interpretation. The results showed the importance of properties related to nitrogen-containing functional groups (SHAP value of PubchemFP656 is -0.29) and aromatic rings (SHAP value of PubchemFP12 is -0.16). As a result, we explained the effect of the molecular fingerprints on the models and the impact on possible drugs that can be developed for FA with artificial intelligence (XAI), which can be explained through SHAP (Shapley Additive Explanations) values. Model scripts and fingerprinting methods are also available at https://github.com/tissueandcells/XAI.https://www.edusoft.ro/brain/index.php/brain/article/view/1427explainable artificial intelligence, friedreich ataxia, predictive accuracy, quantitative structure-activity relationship, qsar, shapley values.
spellingShingle Kevser Kübra Kirboğa
Ecir Uğur Küçüksille
Utku Kose
Ignition of Small Molecule Inhibitors in Friedreich's Ataxia with Explainable Artificial Intelligence
Brain: Broad Research in Artificial Intelligence and Neuroscience
explainable artificial intelligence, friedreich ataxia, predictive accuracy, quantitative structure-activity relationship, qsar, shapley values.
title Ignition of Small Molecule Inhibitors in Friedreich's Ataxia with Explainable Artificial Intelligence
title_full Ignition of Small Molecule Inhibitors in Friedreich's Ataxia with Explainable Artificial Intelligence
title_fullStr Ignition of Small Molecule Inhibitors in Friedreich's Ataxia with Explainable Artificial Intelligence
title_full_unstemmed Ignition of Small Molecule Inhibitors in Friedreich's Ataxia with Explainable Artificial Intelligence
title_short Ignition of Small Molecule Inhibitors in Friedreich's Ataxia with Explainable Artificial Intelligence
title_sort ignition of small molecule inhibitors in friedreich s ataxia with explainable artificial intelligence
topic explainable artificial intelligence, friedreich ataxia, predictive accuracy, quantitative structure-activity relationship, qsar, shapley values.
url https://www.edusoft.ro/brain/index.php/brain/article/view/1427
work_keys_str_mv AT kevserkubrakirboga ignitionofsmallmoleculeinhibitorsinfriedreichsataxiawithexplainableartificialintelligence
AT ecirugurkucuksille ignitionofsmallmoleculeinhibitorsinfriedreichsataxiawithexplainableartificialintelligence
AT utkukose ignitionofsmallmoleculeinhibitorsinfriedreichsataxiawithexplainableartificialintelligence